Literature DB >> 90305

Male infertility due to sulphasalazine.

A I Traub, W Thompson, J Carville.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90305     DOI: 10.1016/s0140-6736(79)91702-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Sulphasalazine in rheumatoid arthritis: an old drug revived.

Authors:  V C Neumann; K A Grindulis
Journal:  J R Soc Med       Date:  1984-03       Impact factor: 5.344

Review 2.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

3.  Nuclear factor-kappa B activation in human testicular apoptosis.

Authors:  Virve Pentikäinen; Laura Suomalainen; Krista Erkkilä; Eeva Martelin; Martti Parvinen; Markku O Pentikäinen; Leo Dunkel
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  Sulphasalazine and male infertility: reversibility and possible mechanism.

Authors:  S Toovey; E Hudson; W F Hendry; A J Levi
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

5.  Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.

Authors:  P Miner; S Hanauer; M Robinson; J Schwartz; S Arora
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

6.  Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas.

Authors:  M Chatzinoff; J M Guarino; S L Corson; F R Batzer; L S Friedman
Journal:  Dig Dis Sci       Date:  1988-01       Impact factor: 3.199

7.  The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.

Authors:  L F Perez-Garcia; R J E M Dolhain; S Vorstenbosch; W Bramer; E van Puijenbroek; J M W Hazes; B Te Winkel
Journal:  Hum Reprod Update       Date:  2020-11-01       Impact factor: 15.610

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.